1. Cell Cycle Inhibition without Disruption of Neurogenesis Is a Strategy for Treatment of Aberrant Cell Cycle Diseases: An Update
   Da-Zhi Liu et al, 2012, The Scientific World Journal CrossRef
2. Dimethylarginine dimethylaminohydrolase-1 (DDAH1) is frequently upregulated in prostate cancer, and its overexpression conveys tumor growth and angiogenesis by metabolizing asymmetric dimethylarginine (ADMA)
   Karthik Reddy Kami Reddy et al, 2017, Angiogenesis CrossRef
3. Novel Cellularly Active Inhibitor Regresses DDAH1 Induced Prostate Tumor Growth by Restraining Tumor Angiogenesis through Targeting DDAH1/ADMA/NOS Pathway
   Karthik Reddy Kami Reddy et al, 2019, ACS Comb. Sci. CrossRef
4. Esophageal Squamous Cell Carcinoma Is Accompanied by Local and Systemic Changes in L-arginine/NO Pathway
   Iwona Bednarz-Misa et al, 2020, IJMS CrossRef
5. L-Arginine/Nitric Oxide Pathway Is Altered in Colorectal Cancer and Can Be Modulated by Novel Derivatives from Oxicam Class of Non-Steroidal Anti-Inflammatory Drugs
   Małgorzata Krzystek-Korpacka et al, 2020, Cancers CrossRef